Developmental Expression and Glucocorticoid Control of the Leptin Receptor in Fetal Ovine Lung. by De Blasio, Miles J et al.
RESEARCH ARTICLE
Developmental Expression and
Glucocorticoid Control of the Leptin Receptor
in Fetal Ovine Lung
Miles J. De Blasio1, Maria Boije1, Owen R. Vaughan1, Brett S. Bernstein1, Katie L. Davies1,
Alice Plein1, Sarah L. Kempster2,3, Gordon C. S. Smith3, D. Stephen Charnock-Jones3,
Dominique Blache4, F. B. Peter Wooding1, Dino A. Giussani1, Abigail L. Fowden1, Alison
J. Forhead1,5*
1 Department of Physiology, Development and Neuroscience, University of Cambridge, Downing Street,
Cambridge, United Kingdom, 2 Department of Medicine, University of Cambridge, Addenbrooke’s Hospital,
Cambridge, United Kingdom, 3 Department of Obstetrics and Gynaecology, University of Cambridge, The
Rosie Hospital, Cambridge, United Kingdom, 4 School of Animal Biology, University of Western Australia,
Perth, Western Australia, Australia, 5 Department of Biological and Medical Sciences, Oxford Brookes
University, Oxford, United Kingdom
* ajf1005@cam.ac.uk
Abstract
The effects of endogenous and synthetic glucocorticoids on fetal lung maturation are well-
established, although the role of leptin in lung development before birth is unclear. This study
examinedmRNA and protein levels of the signalling long-form leptin receptor (Ob-Rb) in fetal
ovine lungs towards term, and after experimental manipulation of glucocorticoid levels in
utero by fetal cortisol infusion or maternal dexamethasone treatment. In fetal ovine lungs,
Ob-Rb protein was localised to bronchiolar epithelium, bronchial cartilage, vascular endothe-
lium, alveolar macrophages and type II pneumocytes. Pulmonary Ob-RbmRNA abundance
increased between 100 (0.69 fractional gestational age) and 144 days (0.99) of gestation,
and by 2–4-fold in response to fetal cortisol infusion and maternal dexamethasone treatment.
In contrast, pulmonary Ob-Rb protein levels decreased near term and were halved by gluco-
corticoid treatment, without any significant change in phosphorylated signal transducer and
activator of transcription-3 (pSTAT3) at Ser727, total STAT3 or the pulmonary pSTAT3:
STAT3 ratio. Leptin mRNAwas undetectable in fetal ovine lungs at the gestational ages
studied. These findings demonstrate differential control of pulmonary Ob-Rb transcript abun-
dance and protein translation, and/or post-translational processing, by glucocorticoids in
utero. Localisation of Ob-Rb in the fetal ovine lungs, including alveolar type II pneumocytes,
suggests a role for leptin signalling in the control of lung growth and maturation before birth.
Introduction
Since identification of the obese (ob) gene and its protein product in 1994, and the leptin recep-
tor (Ob-R) in the following year, the physiological functions of leptin in adult life have been
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extensively studied and well-characterised [1, 2, 3]. In adult animals, leptin is a polypeptide
hormone primarily synthesised and secreted by white adipocytes. It has a key role as a nutri-
tional signal in the regulation of energy intake and expenditure, and in the maintenance of
reproductive and immune function [1, 4]. Leptin acts on transmembrane receptors in target
cells and there are at least six splice variants of the leptin receptor gene [5]. The long-form lep-
tin receptor Ob-Rb, however, is the only receptor with the cytoplasmic signalling domain to
fully activate a variety of intracellular pathways, including the Janus kinase (JAK) and signal
transducers and activators of transcription (STAT) pathway [5].
In contrast to the adult, relatively little is known about the developmental regulation and
role of leptin in the fetus. In many animal species, including human and sheep, leptin is
detected in the fetal circulation from mid-gestation, and there is widespread expression of lep-
tin receptors in fetal and placental tissues [6]. In the sheep fetus, there is a rise in adipose leptin
mRNA and plasma leptin levels with gestational age, coincident with the pre-partum surges in
plasma cortisol and triiodothyronine (T3), and which can be abolished by fetal adrenalectomy
and stimulated prematurely in response to endogenous and synthetic glucocorticoid treatment
[7, 8, 9]. Furthermore, synthetic glucocorticoids such as dexamethasone, administered to preg-
nant women at risk of preterm delivery, cause an increase in umbilical cord blood leptin con-
centrations in the neonate [10].
The rise in cortisol in the fetal circulation near term is known to have maturational effects
in the fetus that are essential for the successful transition to the extrauterine environment at
birth [11]. In particular, cortisol promotes pulmonary maturation in utero and normal respi-
ratory function at delivery. Antenatal synthetic glucocorticoids aid fetal lung maturation,
prevent respiratory distress and improve survival and health outcomes of the premature
human infant [12]. Endogenous and synthetic glucocorticoids stimulate maturation of a
variety of structural aspects in the fetal lungs, including alveolarisation, thinning of the alve-
olar septae and increased pulmonary collagen and elastin content [13]. They also activate
synthesis of both the lipid and protein components of surfactant and its secretion from type
II pneumocytes in the alveoli [14]. Expression of leptin and leptin receptors has been dem-
onstrated in the fetal lungs of rodent and non-human primate species [15, 16, 17, 18]. How-
ever, the extent to which the maturational effects of glucocorticoids on the fetal lung may
be mediated, at least in part, by leptin is unknown. This study examined the mRNA and pro-
tein content of leptin and its long-form receptor (Ob-Rb), and the phosphorylation status
of STAT3, in fetal ovine lungs during late gestation, and after experimental manipulation
of glucocorticoids by fetal cortisol infusion or by maternal dexamethasone treatment. The
study hypothesised that pulmonary Ob-Rb mRNA and protein levels, and JAK/STAT signal-




All surgical and experimental procedures were carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986 and were approved by the animal ethics committee of the Uni-
versity of Cambridge. Time-dated pregnant Welsh Mountain ewes were housed in individual
pens in sight of other ewes, and fed concentrates (200 g/d; 18% protein and 10 MJ/kg; Sheep
Nuts #6; H&G Beart, Kings Lynn, UK) with hay, water and a salt-lick block ad libitum. Overall,
the animals consumed between 8–11 MJ/d of metabolisable energy.
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Surgical and experimental procedures
Developmental study. Twenty ovine fetuses were examined at 100, 115, 130 and 144 days
(d) of gestation (n = 5 per age group, term approximately 145d). Each group contained a mix-
ture of twin and singleton fetuses.
Fetal cortisol study. Under maternal halothane anaesthesia (1.5% in O2-N2O), catheters
were implanted into the femoral artery and vein of eleven singleton fetuses at approximately
116d of gestation using surgical methods described previously [19]. Food, but not water, was
withheld from the pregnant ewe for 18–24h before surgery. After surgery, fetal and maternal
blood samples (2 ml) were collected daily to monitor maternal and fetal blood gas status. At
least six days after catheterisation, the fetuses were infused intravenously with either cortisol
(2–3 mg/kg/d in 3.0 ml 0.9% saline; EF-Cortelan, GlaxoSmithKline, Brentford, UK; n = 5) or
saline vehicle (3.0 ml/d 0.9% wt/vol; n = 6) for five days from 125d of gestation. The cortisol
dose administered achieves plasma cortisol concentrations observed in fetal sheep near term
without inducing parturition [11]. Tissues were collected at 130d of gestation.
Maternal dexamethasone study. Eleven pregnant ewes carrying singleton fetuses were
injected twice intramuscularly with either dexamethasone (12 mg dexamethasone sodium
phosphate; Merck Sharpe and Dohme Ltd, Hoddesdon, UK; n = 5) in 2 ml saline or saline
(0.9% w/v NaCl; n = 5) at 24h intervals from 125d of gestation. Tissues were collected 10h after
the second maternal injection on 127d of gestation. The dose of dexamethasone administered
is similar to that recommended for clinical use in women threatening with premature delivery
[20].
Blood and tissue collection. The fetuses from all studies were delivered by Caesarean sec-
tion with the ewe under general anaesthesia (20 mg/kg sodium pentobarbitone i.v.). At deliv-
ery, an umbilical arterial blood sample (10 ml) was collected, and the fetus and ewe were
euthanized by barbiturate (200 mg/kg sodium pentobarbitone). The fetal lungs were weighed
and un-inflated samples were fixed in 4% paraformaldehyde (with 0.2% gluteraldehyde in
0.1M phosphate buffer, pH 7.4) and embedded in paraffin wax for histological analysis. Sam-
ples of fetal lung were also frozen in liquid nitrogen and stored at -80°C for biochemical and
molecular analyses. All blood samples collected in the studies were placed into EDTA-contain-
ing tubes and centrifuged at 1000xg and 4°C for 5 min. The plasma samples were stored at
-20°C until analysis.
Biochemical and molecular analyses
Plasma hormone analyses. All radioimmunoassay (RIA) methods were validated for use
with ovine plasma. Plasma leptin concentrations were measured by in-house RIA using ovine
leptin standards as previously described [7, 21]; the lower limit of detection was 0.09 ng/ml and
the inter-assay coefficient of variation was 5%. Plasma cortisol concentrations were measured
by in-house RIA [22] where the lower limit of detection was 1.0–1.5 ng/ml and the inter-assay
coefficient of variation was 12%. Total plasma T3 and thyroxine (T4) concentrations were also
measured by RIA using a commercial kit [23] (ICN Biomedicals, Thame, UK). The lower limits
of detection were 0.07 ng/ml for T3 and 7.6 ng/ml for T4, and the inter-assay coefficients of var-
iation were 10% for both assays.
Immunohistochemistry. Sections (5μm) of fetal lung were cut and mounted. Sections
were de-waxed and rehydrated in xylene and graded percentages of industrial methylated spirit
(100–50% IMS). The sections were incubated in 3% hydrogen peroxide for 15 min to remove
endogenous peroxidases. A heat-activated antigen retrieval stage was carried out by incubating
the slides in 10mM citric buffer (pH 6) in a microwave pressure cooker for 2 min at 800W.
This was followed by a 1h incubation in a humidity chamber with 5% goat serum in 2% bovine
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serum albumin and phosphate-buffered saline (0.01M PBS, pH 7.4; Sigma, Poole, UK) to
reduce non-specific antibody binding. The sections were incubated with a rabbit polyclonal
antibody to the C-terminus of the long-form ovine leptin receptor (1:500 dilution of 0.5 mg/ml;
orb6312, Biorbyt, Cambridge, UK) overnight in a humidity chamber at 4°C. Negative control
samples were incubated in the diluent (5% goat serum in PBS). Protein binding was detected
with a biotinylated goat anti-rabbit secondary antibody using the Vectastain Elite ABC system
(Vector Laboratories, Peterborough, UK) and diaminobenzidine (Sigma, Poole, UK) according
to the manufacturers’ instructions. The sections were counter-stained with methyl green (Vector
Laboratories, Peterborough, UK) at 60°C for 3 min. Slides were scanned using a NanoZoomer
system (Hamamatsu, Hamamatsu City, Japan), and viewed using Nanozoomer Digital Pathology
(NDP) view software.
Quantitative RT-PCR. Frozen samples of fetal lung tissue (15mg) were placed in Lysing
Matrix-D tubes (MP Biomedicals, Loughborough, UK) with 170 μl lysis/binding solution from
a MagMax96 Total RNA Isolation kit (Life Technologies, Paisley, UK) and 0.75 μl β-mercap-
toethanol, and homogenized using a FastPrep-24 (MP Biomedicals, Santa Ana, USA). After
homogenisation, 106 μl 100% isopropanol was added to each sample. Samples were placed into
a MagMAX96 system (Applied Biosystems, Paisley, UK) where RNA was isolated and DNase
treated (TURBO DNase) using the MagMAX96 Total RNA Isolation Kit (Life Technologies).
Sample RNA yields and purities were assessed by a Nanodrop (Thermo Fisher, Loughborough,
UK). Ratios of absorption (260/280nm) of all preparations were between 1.8 and 2.0.
Reverse transcription of mRNA was carried out using a PCR Express machine (Thermo
Fisher) and materials from Promega (Southampton, UK) and Invitrogen (Paisley, UK). For
each sample, 5 μl of DNAse-treated RNA was mixed with 1μl random primers, 1μl deoxyribo-
nucleotide triphosphate mix and 5 μl RNAse-free water, and incubated at 65°C for 2 min. A
master reverse transcription mix was made, consisting of 4 μl first strand buffer, 2 μl dithio-
threitol, 1 μl RNAseOUT and 1 μl Superscript II enzyme. The samples were incubated at room
temperature for 5 min, at 42°C for 50 min and at 70°C for 15 min.
TaqMan qRT-PCR was performed to measure mRNA abundance of target genes in lung
samples. Samples were analysed using a TaqMan 7900HT and data were acquired and pro-
cessed with Sequence Detector v.2.3 software (Applied Biosystems). TaqMan Master Mix
(5 μl), 0.5 μl target gene probe and primer set, and 3.5 μl water, were added to each well of a
96-well HT plate (Applied Biosystems). In addition, 1 μl lung cDNA at 1:20 dilution was added
to each well apart from the non-template controls, where 1 μl of water was added. The
sequences of the TaqMan qRT-PCR probes for leptin, all forms of the leptin receptor (Ob-R)
and the functional long form of the leptin receptor (Ob-Rb) are listed in Table 1. Each sample
was measured in triplicate and normalised to the geometric mean of two housekeeping genes,
GAPDH and cyclophilin A (Table 1) [24, 25]. For each plate, a negative control without cDNA
was used to ensure that no amplicon contamination had occurred in the reaction. In addition,
one cDNA sample was measured on each plate across all assays as a quality control. In order to
Table 1. Primer and reporter sequences used for TaqMan qRT-PCR in the sheep.
Gene Forward Primer Sequence Reverse Primer Sequence Reporter Sequence Reporter dye
Leptin CAAGACGATTGTCACCAGGATCAA CCAGTGACCCTCTGTTTGGA TCACACACGCAGTCCGT FAM
Ob-Rb (long-form) GGAGACAGCCCTCTGTTAAATATGC TGAGCTGTTTATAAGCCCTTGCT CCTCCTCGGCTTCACC FAM
Ob-R (all isoforms) GAGCGCCCTTCTTACCTTTACTA CCAACCGCTGTCAGAATTTTAGGT CACAAGATGTCATATATTTTC FAM
GAPDH GCTACACTGAGGACCAGGTT AGCATCGAAGGTAGAAGAGTGAGT CTCCTGCGACTTCAAC FAM
Cyclophilin A GGTTCCTGCTTTCACAGAATAATTCC GTACCATTATGGCGTGTGAAGTCA CACCCTGGCACATAAA FAM
doi:10.1371/journal.pone.0136115.t001
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compare mRNA abundance of target genes, cycle thresholds (Ct) determined by qRT-PCR
were analysed via the ddCt method as all standard curves were linear and parallel.
Western blotting. Frozen samples of fetal lung (100 mg) were homogenised in 1 ml ice-
cold lysis buffer containing 20 mM Tris, pH 7.4, 1 mM EGTA, 0.01% Triton X-100, 1 mM
sodium pyrophosphate, 1 mM sodium orthovanadate, 10 mM β-glycerol phosphate, 50 mM
sodium fluoride and protease inhibitor cocktail (Roche Diagnostics, Burgess Hill, UK). Samples
were centrifuged at 15,000xg for 10 min at 4°C. The protein concentration of the lysates was
measured by a bicinchoninic acid protein assay (Sigma, Poole, UK). The samples were mixed
with SDS-PAGE gel loading buffer (50 mM Tris-HCl, pH 6.8, 100 mM dithiothreitol, 2% SDS,
10% glycerol, bromophenol blue) and boiled for 5 min.
Equal amounts of sample protein (50 μg) were separated using 7.5% Mini-PROTEAN pre-
cast gels for 40 min at 200V and according to the manufacturer’s instructions (Bio-Rad Labora-
tories Inc., Hemel Hempstead, UK) and transferred for 1.5h at 10V onto nitrocellulose
membrane (Invitrogen, Paisley, UK). The membrane was incubated with 5% non-fat dried
milk in Tris-buffered saline and 0.1% Tween-20 for 1h at room temperature, followed by incu-
bation overnight at 4°C with rabbit polyclonal primary antibodies to (a) the ovine long-form
leptin receptor (Ob-Rb; 2 μg/ml orb6312, Biorbyt, Cambridge, UK), or (b) the mouse phos-
phorylated STAT3 containing Ser727 (0.5 μg/ml sc-8001-R, Insight Biotechnology Ltd, Wem-
bley, UK) or (c) the human STAT3 (1:500, 07–2173, Millipore, Watford, UK). Each membrane
was incubated with a horseradish peroxidase-conjugated anti-rabbit secondary antibody
(1:5,000; Amersham Biosciences, Amersham, UK) for 1h at room temperature. Protein expres-
sion was visualised using the ECL Plus chemiluminescence system according to the manufac-
turer’s instructions (Amersham Biosciences, Amersham, UK) and quantified using ImageJ
software (National Institutes of Health, MD, USA; http://rsb.info.nih.gov/ij/) after normalisa-
tion to Ponceau S staining [26]. Ratios of protein expression were arcsine-transformed before
statistical analysis. The immunoblots showed bands at the expected sizes of around 103kDa
(Ob-Rb) and 90kDa (pSTAT3 and STAT3). All samples from the fetal cortisol study, and the
maternal dexamethasone study, were analysed on a single gel while the samples from the devel-
opmental study were analysed on two gels with a single sample assessed on each. The data
from the developmental study were normalised to the quality control sample in the two gels.
Statistical analysis
All data (S1 File) were analysed for normality, and parametric tests were performed on nor-
mally-distributed data while non-parametric tests were carried out on data that were not nor-
mally distributed (SPSS, Richmond, USA). Developmental data were assessed by one-way
ANOVA followed by the Tukey post-hoc test, whilst data obtained from the fetal cortisol and
maternal dexamethasone studies were compared by the unpaired Student’s t-test with their
respective saline control groups. Pearson correlation analysis was used to determine relation-
ships between plasma hormone (log10 concentration) and leptin receptor levels. Fold changes
from the group mean at 100 d (developmental study) or from the control group mean (fetal
cortisol and maternal dexamethasone studies) are presented as mean ± SEM. Differences
where P<0.05 were regarded as significant.
Results
Fetal body and lung weights
Fetal body weight (100d: 0.76 ± 0.03 kg; 115d: 1.42 ± 0.08 kg; 130d: 2.36 ± 0.23 kg; 144d:
3.50 ± 0.22 kg; P<0.05) and lung wet weight (100d: 33.7 ± 2.9 g; 115d: 60.3 ± 1.4 g; 130d:
73.4 ± 10.0 g; 144d: 84.1 ± 13.0 g; P<0.05) increased, and the relative lung wet weight
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(expressed as a percentage of the body weight; 100d: 4.45 ±0.36%; 115d: 4.30 ± 0.18%; 130d:
3.07 ± 0.17%; 144d: 2.42 ±0.32%; P<0.05) decreased with advancing gestational age. Fetal cor-
tisol infusion and maternal dexamethasone treatment did not affect fetal body weight, or abso-
lute or relative lung weights (data not shown).
Plasma hormone concentrations
Fetal plasma concentrations of cortisol and T3 increased in the untreated fetuses of the devel-
opmental study with advancing gestation (P<0.001); plasma cortisol and T3 were significantly
greater at both 130d and 144d compared to 100d of gestation (P<0.05; Table 2). Plasma leptin
concentration showed an increasing trend between 100d and 144d of gestation, but this failed
to reach significance (P = 0.085; Table 2). Plasma T4 concentration remained unaltered over
the gestational ages studied (Table 2).
Five days of fetal cortisol infusion significantly increased plasma concentrations of cortisol,
T3 and leptin (P<0.05) compared with fetal saline infusion, but had no effect on plasma T4
concentration (Table 2). Maternal dexamethasone administration increased plasma T3 and lep-
tin (P<0.05), and decreased plasma cortisol (P<0.05), in the fetus compared with maternal
saline treatment, but did not affect plasma T4 concentration (Table 2).
Pulmonary localisation of Ob-Rb protein
In the fetal ovine lungs, Ob-Rb protein was present from 100d of gestation throughout the
developing pulmonary tissue, including bronchiolar epithelium (Fig 1A). By 130d of gestation,
Ob-Rb protein was localised to the cells of the bronchial and bronchiolar epithelium, the chon-
drocytes in bronchial cartilage and the vascular endothelium (Fig 1C), and by 144d of gesta-
tion, leptin receptor staining was clearly localised to the type II pneumocytes and macrophages
of the alveoli (Fig 1E and 1F).
Pulmonary mRNA and protein levels of Ob-Rb, and JAK/STAT signalling
Pulmonary leptin Ob-Rb mRNA levels showed a significant increase with gestational age
(P<0.05) and was increased at 115d, 130d and 144d of gestation compared to 100d (P<0.001),
Table 2. Mean (± SEM) plasma hormone concentrations in untreated ovine fetuses between 100 and 144d of gestation, and in glucocorticoid-
treated ovine fetuses at 127–130d of gestation (n = 5–6 in each group). For the developmental study, values in each column with different superscripts
are significantly different from each other (P<0.05; one-way ANOVA followed by Tukey test).
Cortisol (ng/ml) T3 (ng/ml) T4 (ng/ml) Leptin (ng/ml)
Developmental study
100d (n = 5) 3.0 ± 0.6 a 0.12 ± 0.02 a 73.8 ± 5.0 0.78 ± 0.06
115d (n = 5) 4.4 ± 0.3 a 0.15 ± 0.02 a 99.6 ± 2.9 0.89 ± 0.06
130d (n = 5) 9.9 ± 1.4 b 0.21 ± 0.02 b 96.8 ± 10.0 0.85 ± 0.08
144d (n = 5) 59.6 ± 17.3 c 0.36 ± 0.04 c 72.4 ± 8.5 1.07 ± 0.11
Fetal cortisol study
Saline 127–130d (n = 6) 13.4 ± 2.3 0.22 ± 0.02 98.7 ± 16.1 0.69 ± 0.03
Cortisol 127–130d (n = 5) 91.2 ± 20.9* 0.67 ± 0.07* 113.6 ± 12.2 1.06 ± 0.11*
Maternal dexamethasone study
Saline 127–130d (n = 5) 16.1 ± 2.8 0.28 ± 0.06 132.5 ± 11.7 0.72 ± 0.05
Dexamethasone 127–130d (n = 5) 8.6 ± 0.7* 0.77 ± 0.05* 126.3 ± 22.0 1.04 ± 0.06*
* signiﬁcantly different from respective saline control fetuses, P<0.05, unpaired t-test.
doi:10.1371/journal.pone.0136115.t002
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Fig 1. Immunohistochemical localisation of Ob-Rb in fetal ovine lungs during late gestation. Fetal lungs at 100d (A), 115d (B), 130d (C) and 144d (E,
F); negative control at 130d (D). Arrowheads show leptin staining in fetal bronchial and bronchiolar epithelium, and cartilage chondrocytes (C), type II
pneumocytes (F, black) and alveolar macrophages (F, red).
doi:10.1371/journal.pone.0136115.g001
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and at 144d compared with 115d of gestation (P<0.05; Fig 2A). Pulmonary Ob-R (all forms)
mRNA abundance also increased with advancing gestation (P<0.05) and was increased at
144d of gestation compared to 100d and 115d of gestation (P<0.05; Fig 2B). In contrast, Ob-
Rb protein content significantly decreased towards term (P<0.05) and was reduced at 144d
compared to 100d and 115d of gestation (P<0.05, Fig 3A).
Pulmonary Ob-Rb mRNA levels in the cortisol-infused fetuses were significantly greater
than those in the saline-infused fetuses (2.3 fold, P<0.05, Fig 4A), but mRNA abundance of
Fig 2. Mean (± SEM) relative mRNA abundance, normalised to 100d of gestation, of leptin receptors
Ob-Rb (A) and Ob-R (B) in the lungs of sheep fetuses from 100 to 144d of gestation (n = 5 at each age).
Values with different superscripts are significantly different from each other (P<0.05; one-way ANOVA
followed by Tukey test).
doi:10.1371/journal.pone.0136115.g002
Fig 3. Mean (± SEM) pulmonary Ob-Rb protein levels in sheep fetuses (A) from 100 to 144d of
gestation and after glucocorticoids exposure by (B) fetal cortisol infusion and (C) maternal
dexamethasone treatment. For the developmental study, values with different superscripts are significantly
different from each other (P<0.05; one-way ANOVA followed by Tukey test; n = 5 for each age). * significantly
different from respective control saline group, P<0.05, unpaired t-test (n = 5–6 for each group).
doi:10.1371/journal.pone.0136115.g003
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Ob-R (all forms) remained unchanged (Fig 4B). Maternal dexamethasone treatment caused
significant increases in both pulmonary Ob-Rb (4.3 fold, P<0.005, Fig 4C) and Ob-R tran-
scripts (all forms; 2.3 fold, P<0.005, Fig 4D). Lung Ob-Rb protein content was significantly
reduced by both fetal cortisol infusion and maternal dexamethasone administration (P<0.05,
Figs 3B and 4C).
No significant changes in pulmonary protein levels of pSTAT3, STAT3 or pSTAT3:STAT3
ratio were observed with increasing gestational age or glucocorticoid treatment (Table 3). Lep-
tin mRNA was not detected in the fetal ovine lungs at any of the gestational ages studied or
after glucocorticoid treatment.
Relationships between pulmonary Ob-Rb mRNA and protein levels, and
plasma hormone concentrations
In the untreated fetuses studied from 100 to 144d of gestation, significant positive correlations
were observed between plasma leptin and plasma concentrations of cortisol (r = 0.54, n = 20,
P<0.005) and T3 (r = 0.61, n = 20, P<0.005), but not T4. Significant positive relationships were
identified between pulmonary Ob-Rb mRNA abundance and plasma concentrations of cortisol
(r = 0.78, n = 19, P<0.05) and T3 (r = 0.63, n = 19, P<0.05), but not plasma leptin or T4.
Fig 4. Mean (± SEM) relative mRNA abundance, normalised to respective control saline group, of leptin receptors (Ob-Rb and Ob-R) in the lungs of
sheep fetuses exposed to glucocorticoids by fetal cortisol infusion (A, B) andmaternal dexamethasone treatment (C, D; n = 5–6 for each group). *
significantly different from respective control saline group, P<0.05, unpaired t-test.
doi:10.1371/journal.pone.0136115.g004
Table 3. Mean (± SEM) relative protein levels of pulmonary pSTAT3, STAT3 and pSTAT3:STAT3 ratio in untreated ovine fetuses between 100 and
144d of gestation, and in glucocorticoid-treated ovine fetuses at 127–130d of gestation (n = 5–6 in each group). Data are normalised to 100d gesta-
tional age group or respective saline control group, as appropriate. Au, arbitrary units.
pSTAT3 (au) STAT3 (au) pSTAT3:STAT3 (au)
Developmental study
100d (n = 5) 1.00 ± 0.12 1.00 ± 0.10 1.00 ± 0.04
115d (n = 5) 0.91 ± 0.12 0.81 ± 0.15 1.21 ± 0.13
130d (n = 5) 1.01 ± 0.12 0.94 ± 0.09 1.09 ± 0.10
144d (n = 5) 0.67 ± 0.10 0.73 ± 0.12 0.94 ± 0.09
Fetal cortisol study
Saline 127–130d (n = 6) 1.00 ± 0.17 1.00 ± 0.11 1.00 ± 0.09
Cortisol 127–130d (n = 5) 0.86 ± 0.18 0.92 ± 0.11 0.94 ± 0.14
Maternal dexamethasone study
Saline 127–130d (n = 5) 1.00 ± 0.10 1.00 ± 0.10 1.00 ± 0.07
Dexamethasone 127–130d (n = 5) 1.09 ± 0.28 1.01 ± 0.15 0.99 ± 0.16
doi:10.1371/journal.pone.0136115.t003
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Pulmonary leptin Ob-R mRNA (all forms) was significantly related to plasma concentrations
of cortisol (r = 0.65, n = 20, P<0.05) and T3 (r = 0.55, n = 20, P<0.05), but not T4. Significant
negative correlations were observed between mRNA abundance and protein levels of Ob-Rb in
the fetal lungs (r = 0.60, n = 19, P<0.05). Pulmonary Ob-Rb protein levels were inversely
related to plasma concentrations of cortisol (r = -0.65, n = 20, P<0.05) and T3 (r = -0.46,
n = 20, P<0.05), but not plasma leptin or T4 concentrations.
Discussion
This study is the first to report changes in the leptin receptor and its transcript, specifically the
fully active long-form receptor Ob-Rb, in the fetal ovine lung during late gestation and in
response to increased glucocorticoid exposure in utero. With advancing gestational age and
treatment with endogenous and synthetic glucocorticoids, pulmonary Ob-Rb mRNA levels
increased, and yet Ob-Rb protein content decreased, in the sheep fetus. These findings support,
in part, those observed in the baboon fetus where pulmonary Ob-Rb mRNA abundance
increased from 0.34 to 0.89 fraction of gestational age (equivalent to 50d to 130d of gestation in
the sheep fetus) and Ob-R protein was detected only at the late stage of gestation [15]. In addi-
tion, a rise in Ob-Rb mRNA levels has been shown to occur between embryonic days 17 (0.79)
and 20 (0.93) in the lungs of fetal rats [27]. The differential effects of glucocorticoids in utero
on the Ob-Rb transcript and protein in the fetal ovine lungs suggest regulation of transcript
level, translation, and/or post-translational processing. Indeed, a lack of correlation between
mRNA and protein levels for Ob-Rb has been reported previously in the uterus of pigs during
the oestrous cycle and early pregnancy [28]. Furthermore, an increase in Ob-Rb mRNA abun-
dance is observed without any change in Ob-Rb protein content in cultured adrenocortical
cells taken from adult sheep exposed to the synthetic glucocorticoid betamethasone in utero
[29].
The mechanisms responsible for the developmental and glucocorticoid-control of pulmo-
nary Ob-Rb content may be direct and/or indirectly involve other endocrine systems. In the
present study, the changes in Ob-Rb and its transcript seen in the fetal lungs were associated
with increased glucocorticoid activity and elevated plasma concentrations of T3 and leptin [8,
14, 30]. Maternal dexamethasone treatment has also been shown previously to increase plasma
insulin concentration in these sheep fetuses [31]. Putative glucocorticoid and thyroid hormone
response elements have been identified in 2,000-bp upstream of the 5’-region of exon 1 in the
chicken leptin receptor gene [32], and glucocorticoids, T3 and insulin upregulate Ob-Rb
mRNA levels independently in a variety of cell types in vitro [33, 34, 35, 36]. Furthermore, in
rats, elevating fetal corticosterone concentration by maternal nicotine or caffeine treatment is
associated with dose-dependent increments in Ob-Rb mRNA in the fetal liver [37, 38]. Leptin
itself is also able to modulate Ob-Rb expression in a negative feedback mechanism. In common
with hormones and other ligands that bind to cell surface receptors, leptin binding to the leptin
receptor causes internalisation and lysosomal degradation of the hormone, and down-regula-
tion of the receptor [39]. Therefore, high circulating leptin concentration may contribute to the
lower pulmonary Ob-Rb protein levels, and, in turn, maintenance of the pSTAT3:STAT3 ratio
and JAK/STAT signalling, seen in the sheep fetuses exposed to glucocorticoids. Ontogenic and
glucocorticoid-induced changes in the internalisation and trafficking of the leptin receptor in
the developing lungs or other tissues, however, are unknown.
In addition to the Ob-Rb, leptin can bind to at least five other leptin receptor isoforms [5].
These receptors, including the soluble leptin receptor Ob-Re, buffer free leptin concentrations
and facilitate leptin transport in the circulation and within tissues [5]. In the present study, pul-
monary Ob-R mRNA levels, detected with the probe that recognises all forms of the leptin
Glucocorticoids and Lung Leptin Receptors In Utero
PLOSONE | DOI:10.1371/journal.pone.0136115 August 19, 2015 10 / 15
receptor, increase towards term in fetal sheep and in response to maternal dexamethasone
treatment, but not fetal cortisol infusion. The developmental and glucocorticoid-induced
changes in pulmonary Ob-Rb mRNA abundance contribute, in part, to these findings, but it is
possible that there may be coincident effects on the other isoforms of leptin receptor, with
important consequences for the bioavailability of leptin in utero. For example, there may be a
reduction in the gene expression of other Ob-R isoforms in the sheep fetuses infused with corti-
sol. Furthermore, the functionality of the Ob-Rb depends upon the components of the intracel-
lular signalling pathways, which may show developmental and glucocorticoid-sensitive
changes in the lungs of the sheep fetus. Indeed, in the present study, the phosphorylation status
of STAT3 in the ovine fetal lungs appeared to be unaffected by gestational age and glucocorti-
coid treatment, despite reductions in pulmonary Ob-Rb protein content. The JAK/STAT path-
way is known to be influenced by growth factors and cytokines other than leptin, and in a
human lung adenocarcinoma cell line, dexamethasone has been shown to enhance interleukin-
6 activation of JAK/STAT signalling without any direct effect on pSTAT3 (Ser727 or Tyr705)
or STAT3 protein concentration [40].
The cellular localisation of Ob-Rb protein in the fetal ovine lungs is similar to that previ-
ously reported in other species both before and after birth [15, 41]. The widespread presence of
Ob-Rb protein in the pulmonary epithelium of the sheep fetus from at least 100d of gestation
suggests that leptin may have a role in promoting lung growth in utero. Previous studies have
demonstrated that treatment of pregnant mice with leptin causes an increase in the lung weight
of the fetus [27, 42]. In addition, leptin stimulates cell proliferation in a human lung squamous
cell line, and in a primary cell culture of tracheal epithelial cells from wild-type mice but not
db/dbmice with mutated leptin receptors [43]. The ontogenic decrease in Ob-Rb protein levels
in the fetal ovine lungs coincides with progression from the canalicular (80–120d) to saccular
(120d to term) and alveolar (120d to postnatal life) stages of lung development [44]. During
these stages, the pulmonary epithelium becomes thinner and differentiates into distinct popu-
lations of type I and II pneumocytes [44]. Near term, maturational changes in the structure
and function of the fetal pulmonary epithelium are stimulated by the prepartum cortisol surge
[13]. It is possible, therefore, that leptin acts as a stimulus for general lung growth before birth
and that the developmental and glucocorticoid-induced suppression of pulmonary Ob-Rb con-
tributes to the maturational shift towards alveolar thinning and pneumocyte differentiation.
Alternatively, localisation of Ob-Rb protein to type II pneumocytes in the pulmonary epithe-
lium and an overall reduction in lung Ob-Rb protein content seen in the fetuses exposed to
endogenous and exogenous glucocorticoids may be a consequence, rather than cause, of pneu-
mocyte differentiation. Furthermore, maintenance of pulmonary pSTAT3:STAT ratio in
fetuses with lower Ob-Rb protein may indicate an increase in cell-specific leptin signalling dur-
ing lung maturation.
Localisation of Ob-Rb protein to type II pneumocytes in fetal ovine lungs, especially in the
fetuses at 144d of gestation, supports a role for leptin in the activation of surfactant production
near term. In fetal rat lung explants, physiological concentrations of leptin increase mRNA
abundance of surfactant proteins A, B and C and protein levels of surfactant proteins A and B
[18, 42]. Leptin also increases the synthesis of surfactant phospholipids in fetal rat lung
explants and in isolated pneumocytes from fetal rabbits [18, 41]. In addition, antenatal treat-
ment of pregnant rats with leptin increases type II pneumocyte number and surfactant protein
expression in the fetal lungs [27, 42]. In contrast, leptin had no effect on lung compliance,
phospholipid content or surfactant protein expression in a study using fetal sheep in vivo [45].
However, this study used ultrasound-guided intramuscular leptin injection and circulating
concentrations of leptin in utero were not determined. Intravenous leptin infusion for five days
in fetal sheep promotes aspects of lung maturation, including increased pulmonary surfactant
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protein B mRNA abundance [46]. Leptin receptor protein was also evident in alveolar macro-
phages in the fetal ovine lungs near term and leptin may play a role in the development of pul-
monary immune defence mechanisms. Alveolar macrophages taken from leptin-deficient adult
mice show impaired phagocytosis and leukotriene synthesis in vitro which can be restored to
normal by exogenous leptin treatment [47]. Physiological doses of leptin can also stimulate leu-
kotriene synthesis in alveolar macrophages obtained from normal adult rat lungs [48].
Leptin receptor protein was also localised to the chondrocytes of bronchial cartilage in the
fetal ovine lungs. Previous studies have demonstrated the presence of leptin receptor mRNA
and protein in developing cartilage-bone in the mouse fetus [16]. In cell culture of human artic-
ular chondrocytes, leptin has been shown to stimulate chondrocyte proliferation and differenti-
ation, and synthesis of collagen and proteoglycans in the extracellular matrix [49]. Therefore,
leptin may be involved in the growth and development of pulmonary epithelium, type II pneu-
mocytes, macrophages and bronchial cartilage in utero. The absence of leptin mRNA in the
fetal ovine lungs at the gestational ages studied, however, suggests that the developmental and
glucocorticoid-induced actions of leptin via Ob-Rb are likely to be endocrine rather than by
local synthesis and paracrine actions of leptin. There appear to be species differences in pulmo-
nary leptin synthesis before birth as leptin mRNA abundance has been detected in the lungs of
fetal rats which increases with gestational age, and other studies have proposed paracrine inter-
actions between leptin and parathyroid-hormone related protein in the control of surfactant
production in the rat fetus [18, 27]. The presence of leptin receptors in the fetal lungs and their
potential roles in pulmonary growth and maturation may also have consequences for respira-
tory function that extend into neonatal and adult life. Alveolar development is impaired in lep-
tin-deficient ob/obmice from the earliest time point studied at two weeks of postnatal life [50].
The contribution that leptin makes to glucocorticoid-induced lung maturation and the extent
to which respiratory disorders in neonatal and adult life have their origins in leptin dysfunction
before birth remains to be established.
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